Back to Deals
Value £23,000,000
Summary
Astral Systems, a Bristol-based deep-tech company, has secured £23 million in Series A funding to develop nuclear fusion technology.
Summary of transaction details:
- Value: £23 million
- Sector: DeepTech & AI
- Advisor: null
- Key Entities: Astral Systems, Mercia Ventures
- Location: Bristol
Note: Astral Systems' proprietary multi-state fusion technology aims to tackle shortages of medical isotopes used in cancer diagnosis and treatment.
Related Deals in DeepTech & AI
Series A prioritisedOriginal Source
View the original press release or news article describing this transaction in full.
Read Original PostAI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in